background-image

MEDICINAL CANNABIS FROM NEW ZEALAND: LEADING INNOVATION BACKED BY STRONG VALUES

Our story is grounded in our values – it’s who we are, what we stand for and what we offer the world.

Care for people

New Zealand’s medicinal cannabis companies have an undeniable desire to put care and respect for patients first. The industry is made up of passionate organisations with a strong belief in their role as ambassadors and guardians of health and wellness, producing high-quality medicines for those who need them.

Care for the environment

New Zealanders recognise that products are only as good as where they come from, and consider themselves to be guardians of people, place and planet. The industry is committed to producing high-quality medicinal cannabis, while also recognising their role as custodians of the land for future generations.

Our proven expertise in agritech underpins the development of sustainable and efficient medicinal cannabis cultivation and processing practices – including systems to reduce energy and water use to reduce our carbon footprint. We are committed to not just playing our part in reducing our environmental impact, but in leading the change.

Deep collaboration

The New Zealand industry operates with a highly collaborative approach. There is a shared commitment to R&D and to delivering products that are high-quality and safe. New Zealand is built on excellence in applied science with a long and successful history in primary production. Our temperate climate, fertile soil and pristine ocean makes us a world leader in agriculture and horticulture production.

Lessons from our primary production history are being shared with the medicinal cannabis sector, including in plant breeding and the development of new cultivars from New Zealand’s other leading horticulture sectors to develop plants with better yield and more components of medicinal value.

The industry is strongly supported by the government. Public funding is advancing extraction techniques and pharmaceutical dosage forms to deliver cannabinoids. Funding is also accelerating a large genetic database of cultivars and seed stock, organic cultivation methods, as well as cultivation management, post-harvest processing, and waste-stream utilisation technology to improve the efficiency and sustainability of the entire industry.

Trustworthy business environment

New Zealand’s medicinal cannabis companies have developed one of the most stringent operating environments in the world. We follow strict international regulatory requirements with GMP and GACP certified facilities, ensuring ingredients and medicines can be trusted to surpass the highest pharmaceutical standards.

The industry acts with integrity, honesty and transparency. Companies are nimble, which allows them to move quickly to meet country, customer, and market requirements with a guaranteed continuity of supply. Along with its strict adherence to international regulatory requirements, New Zealand is quickly earning a reputation as a trusted supplier of quality products and ingredients around the world.

Discover New Zealand Medicinal Cannabis companies

New Zealand’s medicinal cannabis companies are equipped with state-of-the-art research laboratories, cultivation and production facilities, and are attracting R&D and manufacturing expertise from around the world. The industry is commercially focused, producing high-quality medicines and growing technology.

Ora Pharm Flower - Square 1280

Ora Pharm

Ora Pharm is a leading force in the New Zealand medicinal cannabis industry, playing an instrumental role in contract trimming, processing, packing, exporting, and selling cultivators’ products. With our capability, we can fulfil large-scale contracted orders.

Our experienced team has gained valuable insights from overseas as well as other New Zealand cannabis start-ups, solidifying our competitive advantage through strategic direction and operational excellence.

Our Mission is to provide premium products to give people more choice with managing their health for a better quality of life and to drive the growth and success of the New Zealand medicinal cannabis industry by providing world-class products. We are committed to innovation, regulatory compliance, and quality, ensuring our customers receive premium medicinal cannabis solutions tailored to their needs. Through sustainable practices and strategic partnerships, we aim to enhance global access to high-quality medicinal cannabis.

Our Vision is to provide patients, caregivers and doctors with premium plant-based healthcare products to support everyday wellbeing and improve quality of life. Our vision is also to be a global leader in medicinal cannabis, recognized for our excellence in cultivation, manufacturing, and export. We seek to expand our footprint by capitalising on New Zealand’s regulatory framework, ensuring that our products meet the highest standards while fostering innovation in genetics and contract manufacturing.

Bluelab Company Corporate Image

Bluelab

Bluelab has been the trusted tool for growers committed to exceptional crops for generations. We empower you to master the art of growing with the insights needed to make informed decisions in controlled environments.

Whether you're a home grower or a commercial cultivator, our products measure, monitor, and control nutrient solutions and root zones.

As a global company, we bring inspiration and innovations from the Bay of Plenty, New Zealand, a region known for its vital role in the nation's horticultural success.

Rua Bioscience

Rua Bioscience

Pioneering Purpose-Driven Medicinal Cannabis

Rua Bioscience is dedicated to innovation, sustainability, and unlocking the therapeutic potential of cannabis for patients worldwide. Rooted in the East Coast of Aotearoa New Zealand, Rua was founded with a vision to produce high-quality cannabinoid medicines while creating lasting economic opportunities for its communities.

With a strong focus on cultivation and the characterization of cannabis varieties from the legacy market, Rua is committed to preserving genetic diversity and optimizing plant-based therapeutics. Guided by the Māori principles of kaitiakitanga (guardianship) and whanaungatanga (partnership), Rua operates with integrity, responsibility, and collaboration at every stage—from seed to patient.

Rua Bioscience has made significant strides in the medicinal cannabis industry, expanding into key international markets:

  • Australia: In August 2024, Rua launched its first product featuring New Zealand cannabis genetics in Australia, now one of the world's fastest-growing medicinal cannabis markets.
  • Germany: A renewed three-year agreement with Nimbus Health strengthens Rua’s position in Germany, ensuring continued access to one of Europe’s largest medicinal cannabis markets.
  • United Kingdom: A distribution deal with Target Healthcare, signed in 2023, paves the way for Rua’s entry into the UK, with product availability expected in late 2024.
  • New Zealand: Rua continues to expand at home, securing approval for two new products and achieving record domestic sales by the end of 2024.
  • Global Growth: Partnerships in Portugal are enabling cultivation trials for the European market, while a licensing deal with Apollo Green in Canada is helping to bring Rua’s unique genetics to a global audience.

With a strong foundation and an expanding international footprint, Rua Bioscience is committed to delivering high-quality medicinal cannabis products to patients worldwide.

PURO image jpg for company profile

Puro

Leaders in premium medical cannabis

Puro is New Zealand's largest cultivator of medical cannabis, operating two Marlborough sites strategically selected for exceptional growing conditions. Our Kēkerengū coastal farm is the only BioGro-certified organic cannabis operation in Australasia and one of the very few organically certified farms in the world, while our state-of-the-art Waihopai facility houses our advanced breeding and research programmes.

Founded in 2018, Puro has rapidly established itself as a pioneer in sustainable and trusted cannabis cultivation. Our approach combines cutting-edge science with regenerative agriculture practices, guided by traditional Māori principles of kaitiakitanga (environmental guardianship).

We grow pharmaceutical-grade THC and CBD medical cannabis that meet the most stringent international quality standards. Our products undergo comprehensive third-party testing, ensuring consistent potency, purity, and safety.

Backed by a $13 million government grant to fast-track New Zealand's organic medicinal cannabis industry, Puro is scaling rapidly to meet growing global demand. Strategic partnerships with leading pharmaceutical companies across New Zealand, Australia and Europe, position us at the forefront of the booming medical cannabis market.

Our diverse team of world-class experts continues to drive innovation in cultivation techniques and genetics, setting new standards for quality and sustainability in the medical cannabis industry.

By the numbers

Icons Business-16
25th
out of 133 countries for global contribution to Science & Technology
The World Intellectual Property Organization (WIPO) - 2024
Icons Finance-09
US$100M
Estimated New Zealand market size in 2026
Statista
Icons Sectors NZ
41
licensed medicinal cannabis companies (growers, processors, distributors)
background-image

Contact us

For more information on the New Zealand Medicinal Cannabis sector, or to connect with New Zealand businesses, contact us for support from NZTE’s team in your region.

We’re ready to help and look forward to hearing from you.

Follow us:
NZ Trade And Enterprise
  • Sitemap
  • Privacy Policy
  • Cookie Policy
  • Terms of Use & Engagement
New Zealand Government

2026 New Zealand Trade and Enterprise. All rights reserved.